Novartis reported 9.52B in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Alcon AG ALC:SW 1.19B 26M
Amgen AMGN:US $ 5097M 208M
AstraZeneca AZN:LN 6.04B 15M
Bayer BAYN:GR 5.89B 414M
Biogen BIIB:US $ 2267.1M 48.2M
Bristol Myers Squibb BMY:US $ 9333M 81M
Eli Lilly And LLY:US $ 5342M 555.1M
Fresenius FRE:GR € 2523M 95M
Fresenius Medical Care FME:GR € 1267M 16.99M
Gilead Sciences GILD:US $ 6198M 1371M
GlaxoSmithKline GSK:LN 6.26B 682M
GRIFOLS GRF:SM € 580.8M 47.47M
H. Lundbeck A/S LUN:DC 3.16B 53M
Hikma Pharmaceutical HIK:LN 616M 5M
Johnson & Johnson JNJ:US $ 16088M 343M
Lonza Group LONN:SW 1.04B 418M
Merck MRK:GR € 3114M 57M
Merk MRK:US $ 10098M 1738M
Novartis NOVN:VX 9.52B 21M
Novartis NVS:US $ 9519M 21M
Orion ORNBV:FH 130.6M 24.7M
Pfizer PFE:US $ 14163M 2178M
Philips PHIA:NA € 1974M 185M
Recordati REC:IM 278.29M 5.84M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M